ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Chronic Renal Insufficiency
Kidney Diseases
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Insufficiency
Renal Cell Carcinoma
Kidney Cancer

Kidney Disease trials near Louisville, KY, USA:

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

The purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease...

Enrolling
Proteinuric Kidney Disease
Drug: MZE829

Phase 2

Maze Therapeutics

Louisville, Kentucky, United States and 85 other locations

Locations recently updated

This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...

Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Empagliflozin

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Louisville, Kentucky, United States and 103 other locations

of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...

Active, not recruiting
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Louisville, Kentucky, United States and 762 other locations

disease (ASCVD) or diabetes with end stage kidney disease (ESKD) undergoing maintenance dialysis....

Enrolling
End Stage Kidney Disease
Drug: Placebo
Drug: CSL300

Phase 2, Phase 3

CSL Behring
CSL Behring

Louisville, Kentucky, United States and 546 other locations

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take p...

Enrolling
Kidney Disease, Chronic
Drug: Placebo matching BI 690517
Drug: BI 690517

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Louisville, Kentucky, United States and 481 other locations

The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA...

Active, not recruiting
Immunoglobulin A Nephropathy
IgA Nephropathy
Drug: Placebo
Drug: Zigakibart

Phase 3

Novartis
Novartis

Louisville, Kentucky, United States and 136 other locations

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of praliciguat in adu...

Enrolling
Focal Segmental Glomerulosclerosis
Drug: Praliciguat
Other: Placebo

Phase 2

Akebia Therapeutics
Akebia Therapeutics

Louisville, Kentucky, United States and 23 other locations

implicated in the inflammatory chemokine environment of chronic disease. The purpose of this pivotal randomized double-blind study is to inv...

Enrolling
FSGS
Drug: DMX-200
Drug: Placebo

Phase 3

Dimerix Bioscience

Louisville, Kentucky, United States and 220 other locations

The purpose of this study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney d...

Enrolling
CKD
Metabolic Acidosis
Drug: Placebo
Drug: Veverimer

Phase 3

Renibus Therapeutics

Louisville, Kentucky, United States and 25 other locations

given intravenously (IV) to adults and adolescents with sickle cell disease (SCD) experiencing vaso-occlusive crises (VOC). The main objecti...

Enrolling
Sickle Cell Disease Vaso-occlusive Crisis
Drug: Placebo
Biological: CSL889

Phase 2

CSL Behring
CSL Behring

Louisville, Kentucky, United States and 19 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems